Learn how to select appropriate cardiac tests based on symptoms, risk stratification, and clinical context for chest pain, palpitations and syncope.

Published: May 8, 2026

When it comes to cardiac disease diagnosis in the primary care setting, choosing the right cardiac diagnostic test depends on several factors, including risk stratification, symptom frequency and clinical context. Here is a practical guide to navigating cardiology testing in primary care, adapted from a continuing medical education presentation by Mostafa O. El-Refai, M.D., interventional cardiologist with Norton Heart & Vascular Institute.

Chest pain: Start with risk assessment

Most patients with chest pain do not have conditions such as heart failure or obstructive coronary artery disease. Many symptoms, such as chest pain, mimic those of cardiovascular disease or heart attack, but may be the result of gastrointestinal issues, panic and anxiety, and respiratory conditions. Before ordering cardiac diagnostic tests, evaluate age, gender, risk factors and symptom characteristics to determine pretest probability.

The American College of Cardiology (ACC) guidelines recommend starting with an electrocardiogram (EKG) for initial evaluation, though 5% of acute myocardial infarctions demonstrate no EKG changes. Transthoracic echocardiography serves as a useful screening test, revealing pericardial effusions, regional wall motion abnormalities and left ventricular ejection fraction without radiation exposure.

For low-risk to intermediate-risk patients, exercise treadmill testing remains a reasonable first-line test. The Bruce protocol provides metabolic equivalent data and EKG changes during physiologic stress. Patients who achieve target heart rate and appropriate metabolic equivalents for age without ischemic changes generally have favorable prognoses.

Adding imaging for better sensitivity

Single-photon emission computed tomography (SPECT) and stress echocardiography add imaging to standard exercise testing. SPECT uses radiotracer injection to assess myocardial perfusion, while stress echocardiography evaluates regional wall motion abnormalities. Both are functional tests assessing myocardial blood flow rather than coronary anatomy.

SPECT imaging can produce artifacts from breast tissue, diaphragmatic attenuation or gastrointestinal tracer uptake. Positron-emission tomography (PET) myocardial perfusion imaging helps reduce these artifacts in patients with elevated body mass index or prior equivocal studies. Stress echocardiography requires adequate acoustic windows. Dobutamine serves as the pharmacologic stress agent but can precipitate arrhythmias or hemodynamic instability, making it less favorable than exercise-based protocols when patients have functional capacity.

Coronary CT angiography: The rising star

For patients under 65 with low-to-intermediate pretest probability, coronary CT angiography (CCTA) now represents a Class I recommendation in ACC guidelines. Unlike functional tests, CCTA provides direct visualization of coronary anatomy and can detect nonobstructive atherosclerotic disease — valuable for risk stratification and intensification of medical therapy in younger patients.

The test requires heart rate control, typically below 75 beats per minute with beta-blocker pretreatment. Coronary artery calcium (CAC) scores above 400 to 600 limit diagnostic accuracy due to blooming artifact.

When CCTA identifies an intermediate stenosis, CT-derived fractional flow reserve (FFR-CT) now can determine whether the blockage is actually causing ischemia — providing both anatomic and functional information from a single noninvasive test. This is an artificial intelligence-powered tool that analyzes the CT data to assess hemodynamic significance, avoiding the need for invasive testing in many cases.

Palpitations: Match monitor duration to symptom frequency

Most individuals experience premature atrial contractions and premature ventricular contractions. Ectopic burden under 1% is physiologic; under 5% rarely requires intervention. Choose monitoring duration based on symptom frequency. A Holter monitor is optimal for daily symptoms. Ambulatory event monitors lasting one to four weeks are appropriate for weekly symptoms.

For infrequent symptoms occurring every few months, consumer wearable devices can capture useful data — but with an important distinction. Heart-rate-only devices (many fitness trackers and basic smartwatches) are limited for arrhythmia detection. Devices with single-lead ECG capability, such as the Apple Watch or KardiaMobile, can produce clinically useful rhythm strips that may document the culprit arrhythmia. Use caution in patients with health anxiety, who may overuse these devices to amplify worry rather than provide reassurance.

Lightheadedness and syncope

Most lightheadedness and syncope presentations are noncardiac in etiology. Orthostatic hypotension represents autonomic dysfunction, and vasovagal syncope accounts for most syncopal episodes. When cardiac causes require exclusion, order ambulatory monitoring matched to symptom frequency, plus transthoracic echocardiography to assess for structural abnormalities, including aortic stenosis or hypertrophic obstructive cardiomyopathy.

For unexplained recurrent syncope, electrophysiology consultation can place an implantable loop recorder with three-year battery life.

Edema evaluation

Remember that chronic venous insufficiency, not heart failure, causes most bilateral lower extremity edema. When cardiac etiologies require exclusion, a blood test such as B-type natriuretic peptide and transthoracic echocardiography provide reasonable initial workup.

Advanced imaging, including cardiac MRI and transesophageal echocardiography, typically require cardiology referral for specific clinical indications.

The bottom line

Successful cardiac diagnostic testing begins with appropriate risk stratification using clinical presentation, age, gender and cardiovascular risk factors. Match test selection to pretest probability, patient characteristics and symptom patterns. When clinical suspicion remains elevated despite negative noninvasive testing, escalate to invasive evaluation. Most importantly, remember that negative testing in truly low-risk patients may cause more harm than benefit through incidental findings and downstream procedures.

Clinical pearls

• Compare serial EKGs. Repeat EKGs can establish a baseline for patients with chronically abnormal electrocardiograms and otherwise stable findings. Left ventricular hypertrophy with strain pattern unchanged over five years has different clinical significance than acute ST-segment changes.
• Use calcium scoring for risk stratification. A 40-year-old with low-density lipoprotein (LDL) cholesterol level 140 milligrams per deciliter and CAC score of 0 often can defer statin therapy. A CAC score of 50 in the same patient indicates subclinical atherosclerosis warranting aggressive lipid management even without flow-limiting stenoses. To contextualize a patient’s calcium score, use the Multi-Ethnic Study of Atherosclerosis calcium score calculator — entering age, gender and race provides a population-based percentile that clarifies whether a given score is truly elevated for that patient’s demographic.
• Match the monitor to symptom frequency. Ambulatory monitoring during asymptomatic periods doesn’t answer the clinical question. If palpitations occur weekly, order a two-week event monitor rather than using a 24-hour Holter monitor.
• Exercise preferred over pharmacologic stress when feasible. While stress echocardiography with treadmill exercise offers good diagnostic yield, pharmacologic stress with dobutamine can trigger atrial fibrillation with rapid ventricular response or ventricular arrhythmias. For patients unable to exercise, nuclear SPECT with regadenoson provides safer pharmacologic stress.
• Coronary angiography requires adequate preparation. Heart rates above 75 beats per minute produce motion artifact compromising diagnostic accuracy. Order metoprolol 50 to 100 milligrams one hour prescan and confirm adequate rate control. Patients with chronic sinus tachycardia or uncontrolled atrial fibrillation are poor candidates.
• Interpret artifact reports appropriately. When nuclear studies report “soft tissue attenuation” or “inferior wall artifact secondary to diaphragmatic attenuation,” the study has technical limitations. In patients with high pretest probability, consider PET myocardial perfusion imaging or proceed directly to invasive coronary angiography rather than repeating SPECT.
• Objective testing reduces anxiety. Low-risk patients with atypical chest pain often benefit from diagnostic testing for reassurance rather than diagnosis. A negative stress test in appropriate clinical context provides therapeutic benefit beyond medical management.
• Functional versus anatomic testing. Stress tests (nuclear, echocardiogram, exercise EKG) assess physiologic significance of stenoses but miss nonobstructive disease. CCTA visualizes plaque burden, including subclinical atherosclerosis, informing aggressive preventive strategies in young patients.
• Diabetes confers the same cardiovascular risk as a prior myocardial infarction. It is an independent, high-level risk factor that should elevate clinical suspicion and drive more aggressive risk stratification even in otherwise low-appearing presentations.
• CCTA findings directly inform LDL targets. If CCTA reveals moderate nonobstructive plaque in a 55-year-old, the appropriate LDL target may shift to below 55 milligrams per deciliter rather than below 100 milligrams per deciliter—— driven by direct visualization of subclinical atherosclerosis, even in the absence of flow-limiting stenosis.
• Fixing a blockage in an asymptomatic patient does not reduce heart attack risk or mortality. Routine stress testing is not recommended for asymptomatic individuals. Testing should be driven by symptoms and risk factors, not by a desire to rule out disease in someone who feels well.
• Red flag palpitations warrant urgent workup. Sustained palpitations combined with lightheadedness, dizziness or syncope should raise concern for a pathologic arrhythmia and accelerate the diagnostic evaluation.
• Tilt table testing retains value for postural orthostatic tachycardia syndrome and autonomic dysfunction despite a high false-positive rate of approximately 30% to 35%. It is most useful when confirming the diagnosis has direct therapeutic implications.
• Medication reconciliation is essential in syncope workup. Patients losing weight on GLP-1 receptor agonists may develop orthostatic hypotension if antihypertensive regimens are not adjusted. Proactive review can prevent these episodes.
• Heart failure is a clinical diagnosis, not just an imaging finding. A patient with an ejection fraction of 10% who has never experienced volume overload symptoms has cardiomyopathy, not heart failure. The diagnosis requires both structural abnormality and symptoms of congestion — a distinction that matters for documentation, prognosis and treatment framing.